Back to Journals » Therapeutics and Clinical Risk Management
Therapeutics and Clinical Risk Management
- View all (2612)
- Volume 22, 2026 (56)
- Volume 21, 2025 (162)
- Volume 20, 2024 (86)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Journal Articles:
- Older and newer players in the therapeutics of Cardio-Kidney-Metabolic syndrome (1)
- Machine Learning in the Realm of Therapeutics and Clinical Risk Management (1)
- Lymphoproliferation at the crossroad between hematology and immunology: molecular and clinical implications (1)
- Anticholinergic Therapies for the Treatment of Asthma (7)
Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota
Rabbani SA, El-Tanani M, Janić M, Janež A, Tanani YE, Hajeer E, Matalka MI, Rizzo M, Kumar R
Therapeutics and Clinical Risk Management 2025, 21:1701-1733
Published Date: 13 December 2025
Leveraging 3D Convolutional Neural Networks for Accurate Recognition and Localization of Ankle Fractures
Wang H, Ying J, Liu J, Yu T, Huang D
Therapeutics and Clinical Risk Management 2024, 20:761-773
Published Date: 20 November 2024
The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases
Costagliola G, De Marco E, Massei F, Roberti G, Catena F, Casazza G, Consolini R
Therapeutics and Clinical Risk Management 2024, 20:261-274
Published Date: 16 May 2024
Unmet needs in asthma
Gruffydd-Jones K
Therapeutics and Clinical Risk Management 2019, 15:409-421
Published Date: 14 March 2019
Choosing the right inhaler for your asthma or COPD patient
Usmani OS
Therapeutics and Clinical Risk Management 2019, 15:461-472
Published Date: 14 March 2019
Clinical efficacy and safety of anticholinergic therapies in pediatric patients
Goldstein S
Therapeutics and Clinical Risk Management 2019, 15:437-449
Published Date: 14 March 2019
Preschool children with persistent asthmatic symptoms
Vogelberg C
Therapeutics and Clinical Risk Management 2019, 15:451-460
Published Date: 14 March 2019
Barriers to achieving asthma control in adults: evidence for the role of tiotropium in current management strategies
Jenkins C
Therapeutics and Clinical Risk Management 2019, 15:423-435
Published Date: 14 March 2019
Future perspectives of anticholinergics for the treatment of asthma in adults and children
Buhl R, Hamelmann E
Therapeutics and Clinical Risk Management 2019, 15:473-485
Published Date: 14 March 2019
Anticholinergics in asthma: are we utilizing asthma therapies effectively?
Vogelberg C
Therapeutics and Clinical Risk Management 2019, 15:405-408
Published Date: 14 March 2019